- Healthcare Professionals
Lauryn was diagnosed with an SVT when she was six years old. Over the last 20+ years, she has had a sudden heart rate increase every two to three months, forcing her to drop everything and use techniques taught to her by clinicians to relieve her symptoms. The onset of these episodes would often scare the people around her. As she got older, the frequency and duration of her episodes increased, often causing her to miss out on moments with her family and friends. Having to manage this SVT prevented her from doing what she wanted to on a day-to-day basis.
Her life was changed after she wore a CAM patch monitor that finally diagnosed this SVT with a specific atrial arrhythmia that was clinically actionable. Her doctor reassured her that the AVRT seen on the report could be treated with an EP study and ablation. Since her ablation in December 2020, she hasn’t had any reoccurrence of episodes. The CAM patch’s actionable diagnostic finding changed her life and ultimately allowed her to live a normal life without worrying about managing ambiguous SVT episodes.1
Interested in receiving more patient stories, case studies, or industry trend information? Please subscribe here.
CAM is the ONLY cardiac monitoring report that identifies all significant subtypes of atrial arrhythmias (AF, AFL, AT, AVRT, AVNRT, and PAC) instead of just SVT. Why use ECG monitors that still report an unspecific diagnosis of SVT, when a CAM report can give you the actual atrial arrhythmia diagnosis? See a sample report and learn more about the CAM patch.
Please complete the form below, and a local account representive will be in touch with you shortly.
"*" indicates required fields
US-FLC199-230047 v1.0 11/2023
1. Smith WM, Riddell F, Madon M, et al. Comparison of diagnostic value using a small, single channel, P-wave centric sternal ECG monitoring patch with a standard 3-lead Holter system over 24 hours. Am Heart J 2017; 185:67-73.
2. Rho R, Vossler M, Blancher S, Poole JE. Comparison of two ambulatory patch ECG monitors: The benefit of the P-wave and the signal clarity. Am Heart J 2018; 203:109-117.
3. Patient testimonial and consent on file. Baxter, 2023.
Rx Only. Indication for Use: The Carnation Ambulatory Monitor is designed to provide extended-duration cardiac monitoring for people who are suspected of having cardiac arrhythmias. Please refer to the Instruction for Use for further information. © Bardy Diagnostics. All rights reserved. Bardy Diagnostics, Bardy Diagnostics logo, and Carnation Ambulatory Monitor (CAM) are trademarks of Bardy Diagnostics, a part of Baxter.